Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 8
2005 6
2006 5
2007 3
2008 6
2009 5
2010 8
2011 13
2012 3
2013 6
2014 13
2015 7
2016 6
2017 9
2018 13
2019 25
2020 13
2021 23
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

154 results
Results by year
Filters applied: . Clear all
Page 1
Hereditary spherocytosis.
Perrotta S, Gallagher PG, Mohandas N. Perrotta S, et al. Lancet. 2008 Oct 18;372(9647):1411-26. doi: 10.1016/S0140-6736(08)61588-3. Lancet. 2008. PMID: 18940465
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.
Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, Voskaridou E, Liew HK, Pazgal-Kobrowski I, Forni GL, Perrotta S, Khelif A, Lal A, Kattamis A, Vlachaki E, Origa R, Aydinok Y, Bejaoui M, Ho PJ, Chew LP, Bee PC, Lim SM, Lu MY, Tantiworawit A, Ganeva P, Gercheva L, Shah F, Neufeld EJ, Thompson A, Laadem A, Shetty JK, Zou J, Zhang J, Miteva D, Zinger T, Linde PG, Sherman ML, Hermine O, Porter J, Piga A; BELIEVE Investigators. Cappellini MD, et al. Among authors: perrotta s. N Engl J Med. 2020 Mar 26;382(13):1219-1231. doi: 10.1056/NEJMoa1910182. N Engl J Med. 2020. PMID: 32212518 Clinical Trial.
Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with β-thalassemia.
Piga A, Perrotta S, Gamberini MR, Voskaridou E, Melpignano A, Filosa A, Caruso V, Pietrangelo A, Longo F, Tartaglione I, Borgna-Pignatti C, Zhang X, Laadem A, Sherman ML, Attie KM. Piga A, et al. Among authors: perrotta s. Blood. 2019 Mar 21;133(12):1279-1289. doi: 10.1182/blood-2018-10-879247. Epub 2019 Jan 7. Blood. 2019. PMID: 30617198 Free PMC article. Clinical Trial.
Clinical and Genetic Findings in Children with Neurofibromatosis Type 1, Legius Syndrome, and Other Related Neurocutaneous Disorders.
Giugliano T, Santoro C, Torella A, Del Vecchio Blanco F, Grandone A, Onore ME, Melone MAB, Straccia G, Melis D, Piccolo V, Limongelli G, Buono S, Perrotta S, Nigro V, Piluso G. Giugliano T, et al. Among authors: perrotta s. Genes (Basel). 2019 Jul 31;10(8):580. doi: 10.3390/genes10080580. Genes (Basel). 2019. PMID: 31370276 Free PMC article.
Hearing Loss in Beta-Thalassemia: Systematic Review.
Tartaglione I, Carfora R, Brotto D, Barillari MR, Costa G, Perrotta S, Manara R. Tartaglione I, et al. Among authors: perrotta s. J Clin Med. 2021 Dec 25;11(1):102. doi: 10.3390/jcm11010102. J Clin Med. 2021. PMID: 35011846 Free PMC article. Review.
Effects of Iron Chelation in Osteosarcoma.
Argenziano M, Di Paola A, Tortora C, Di Pinto D, Pota E, Di Martino M, Perrotta S, Rossi F, Punzo F. Argenziano M, et al. Among authors: perrotta s. Curr Cancer Drug Targets. 2021;21(5):443-455. doi: 10.2174/1568009620666201230090531. Curr Cancer Drug Targets. 2021. PMID: 33380300
Nineteen-month-old girl with persistent fever.
Marzuillo P, Guarino S, Casale M, Di Sessa A, Golino R, D'Angelo V, Menna G, Rossi F, Miraglia Del Giudice E, Perrotta S. Marzuillo P, et al. Among authors: perrotta s. Arch Dis Child Educ Pract Ed. 2020 Oct;105(5):308-310. doi: 10.1136/archdischild-2018-316493. Epub 2019 Feb 23. Arch Dis Child Educ Pract Ed. 2020. PMID: 30798252 No abstract available.
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.
Russo G, De Franceschi L, Colombatti R, Rigano P, Perrotta S, Voi V, Palazzi G, Fidone C, Quota A, Graziadei G, Pietrangelo A, Pinto V, Ruffo GB, Sorrentino F, Venturelli D, Casale M, Ferrara F, Sainati L, Cappellini MD, Piga A, Maggio A, Forni GL. Russo G, et al. Among authors: perrotta s. Orphanet J Rare Dis. 2019 May 30;14(1):120. doi: 10.1186/s13023-019-1099-0. Orphanet J Rare Dis. 2019. PMID: 31146777 Free PMC article. Review.
154 results